Table 1. The effects of BBR on liver PAP, triglyceride, and cholesterol content in experimental groups.

Groups	PAP activity (nmol phosphate/min/mg protein)	Liver TG (mg/g wet tissue)	Liver cholesterol (mg/g wet tissue)
Group I (control)	15.02±0.63	3.91±0.29	2.22±0.35
Group II	12.05±0.41*	2.59±0.33*	1.64±0.22*
Group III	12.06±0.48*†	8.28±0.41#*†	4.13±0.25*†
Group IV	11.17±0.65*	10.86±0.26*	8.12±0.72*
Group V	12.13±0.46*†	6.65±0.59#*†	4.43±0.85*†

The data were expressed as Mean±SD; n=8 in each group. Group I: Normal diet; Group II: Normal diet supplemented with 90 mg/kg body weight BBR; Group III: Hyperlipidemic rats treated with 90 mg/kg body weight BBR; Group IV: Hyperlipidemic rats without treatment; Group V: Hyperlipidemic rats treated with 30 mg/kg body weight gemfibrozyl. *: P<0.05 compared with the corresponding value for Group I; ^†: P<0.05 compared with the corresponding value for Group IV; ^#: P<0.05 compared with the corresponding value for Group V.